Roppelt A, Markina U, Beloglazova I, Parshin V, Kanner D, Pershin D
Front Immunol. 2025; 15:1523256.
PMID: 39959585
PMC: 11825476.
DOI: 10.3389/fimmu.2024.1523256.
Wang C, Freeman A
Pathogens. 2024; 13(11).
PMID: 39599507
PMC: 11597637.
DOI: 10.3390/pathogens13110955.
Caldarelli M, Rio P, Giambra V, Gasbarrini A, Gambassi G, Cianci R
Vaccines (Basel). 2024; 12(10).
PMID: 39460349
PMC: 11511404.
DOI: 10.3390/vaccines12101183.
Saito K, Fujimoto M, Funajima E, Serada S, Ohkawara T, Ishihara M
J Allergy Clin Immunol Glob. 2024; 3(4):100312.
PMID: 39253104
PMC: 11381862.
DOI: 10.1016/j.jacig.2024.100312.
Atschekzei F, Traidl S, Carlens J, Schutz K, von Hardenberg S, Elsayed A
Front Immunol. 2024; 15:1400348.
PMID: 39247195
PMC: 11377292.
DOI: 10.3389/fimmu.2024.1400348.
Immunophenotyping and Therapeutic Insights from Chronic Mucocutaneous Candidiasis Cases with STAT1 Gain-of-Function Mutations.
Lei W, Lo Y, Tsumura M, Ding J, Lo C, Lin Y
J Clin Immunol. 2024; 44(8):184.
PMID: 39177867
DOI: 10.1007/s10875-024-01776-9.
Retrospective identification of the first cord blood-transplanted severe aplastic anemia in a -associated chronic mucocutaneous candidiasis family: case report, review of literature and pathophysiologic background.
Fink F, Hopfl R, Witsch-Baumgartner M, Kropshofer G, Martin S, Fink V
Front Immunol. 2024; 15:1430938.
PMID: 39114664
PMC: 11303233.
DOI: 10.3389/fimmu.2024.1430938.
A human STAT3 gain-of-function variant drives local Th17 dysregulation and skin inflammation in mice.
Toth K, Schmitt E, Kolicheski A, Greenberg Z, Levendosky E, Saucier N
J Exp Med. 2024; 221(8).
PMID: 38861030
PMC: 11167377.
DOI: 10.1084/jem.20232091.
Patients with STAT1 Gain-of-function Mutations Display Increased Apoptosis which is Reversed by the JAK Inhibitor Ruxolitinib.
Dotta L, Todaro F, Baronio M, Giacomelli M, Pinelli M, Giambarda M
J Clin Immunol. 2024; 44(4):85.
PMID: 38578354
PMC: 10997685.
DOI: 10.1007/s10875-024-01684-y.
Ruxolitinib Improves Immune-Dysregulation Features but not Epigenetic Abnormality in a Patient with STAT1 GOF.
Koh J, Kim D, Son S, Park H, Kim K, Min S
J Clin Immunol. 2024; 44(4):84.
PMID: 38578320
PMC: 10997693.
DOI: 10.1007/s10875-024-01687-9.
Janus kinase inhibitors ameliorate clinical symptoms in patients with STAT3 gain-of-function.
Kaneko S, Sakura F, Tanita K, Shimbo A, Nambu R, Yoshida M
Immunother Adv. 2024; 3(1):ltad027.
PMID: 38549698
PMC: 10977912.
DOI: 10.1093/immadv/ltad027.
Infections in Disorders of Immune Regulation.
Thangaraj A, Tyagi R, Suri D, Gupta S
Pathogens. 2024; 13(3).
PMID: 38535602
PMC: 10976012.
DOI: 10.3390/pathogens13030259.
Aberrant RNA sensing in regulatory T cells causes systemic autoimmunity.
Luca D, Lee S, Hirota K, Okabe Y, Uehori J, Izawa K
Sci Adv. 2024; 10(9):eadk0820.
PMID: 38427731
PMC: 10906915.
DOI: 10.1126/sciadv.adk0820.
A novel gain-of-function STAT3 variant in infantile-onset diabetes associated with multiorgan autoimmunity.
Zhou Q, Chen D, Yu J, Zheng B, Zhou W, Jia Z
Mol Genet Genomic Med. 2024; 12(2):e2407.
PMID: 38404237
PMC: 10895381.
DOI: 10.1002/mgg3.2407.
Progress in molecular diagnosis and treatment of chronic mucocutaneous candidiasis.
Jing D, Liang G, Li X, Liu W
Front Immunol. 2024; 15:1343138.
PMID: 38327523
PMC: 10847319.
DOI: 10.3389/fimmu.2024.1343138.
Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy.
Luo X, He X, Zhang X, Zhao X, Zhang Y, Shi Y
MedComm (2020). 2024; 5(2):e474.
PMID: 38318160
PMC: 10838672.
DOI: 10.1002/mco2.474.
Treg in inborn errors of immunity: gaps, knowns and future perspectives.
Kennedy-Batalla R, Acevedo D, Luo Y, Esteve-Sole A, Vlagea A, Correa-Rocha R
Front Immunol. 2024; 14:1278759.
PMID: 38259469
PMC: 10800401.
DOI: 10.3389/fimmu.2023.1278759.
Signal Transducer and Activator of Transcription Proteins at the Nexus of Immunodeficiency, Autoimmunity and Cancer.
Liongue C, Sobah M, Ward A
Biomedicines. 2024; 12(1).
PMID: 38255152
PMC: 10813391.
DOI: 10.3390/biomedicines12010045.
CVID-Associated Intestinal Disorders in the USIDNET Registry: An Analysis of Disease Manifestations, Functional Status, Comorbidities, and Treatment.
Franzblau L, Fuleihan R, Cunningham-Rundles C, Wysocki C
J Clin Immunol. 2023; 44(1):32.
PMID: 38133694
DOI: 10.1007/s10875-023-01604-6.
Ruxolitinib Rescues Multiorgan Clinical Autoimmunity in Patients with APS-1.
Levy R, Escudier A, Bastard P, Briand C, Polivka L, Stoupa A
J Clin Immunol. 2023; 44(1):5.
PMID: 38112858
PMC: 10730634.
DOI: 10.1007/s10875-023-01629-x.